JoVE Logo

Войдите в систему

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Oxidative reactions are pivotal in metabolizing numerous compounds, including pharmaceutical drugs. These reactions often occur in carbon-heteroatom systems, such as carbon-nitrogen, carbon-sulfur, and carbon-oxygen.

In carbon-nitrogen systems, aliphatic and aromatic amines can undergo oxidative reactions. Secondary and tertiary amines, like those found in tricyclic antidepressants, can undergo N-dealkylation, a process that involves the oxidation of the alkyl group. In addition, oxidative deamination can occur, resulting in the formation of simpler amines, such as amphetamine.

Additional transformations can also occur, such as N-oxide formation in basic nitrogen atoms and N-hydroxylation in non-basic nitrogen atoms or those lacking an α-hydrogen.

Carbon-sulfur systems can undergo processes like S-dealkylation, S-alkylation, desulphurization, and S-oxidation. Sulphonamides and thiols, commonly found in various drugs, typically undergo these reactions. In contrast, carbon-oxygen systems predominantly undergo O-dealkylation. A classic example of a drug undergoing this type of reaction is codeine.

In addition to these specific reactions, there are also miscellaneous oxidative reactions. For example, reductive dehalogenation can occur in fluorocarbons like halothane, and the reduction of sulfur-containing groups can be seen in drugs like disulfiram. Understanding these complex biochemical reactions is critical in the pharmaceutical industry. Researchers and healthcare professionals can design and administer safer and more effective therapies by understanding how different compounds interact with the body's metabolic processes.

Теги

Phase I ReactionsOxidative ReactionsCarbon heteroatom SystemsCarbon nitrogen SystemsAliphatic AminesN dealkylationOxidative DeaminationCarbon sulfur SystemsS oxidationSulphonamidesO dealkylationCodeineMiscellaneous Oxidative ReactionsReductive DehalogenationPharmaceutical Industry

Из главы 5:

article

Now Playing

5.4 : Phase I Reactions: Oxidation of Carbon-Heteroatom and Miscellaneous Systems

Pharmacokinetics: Drug Biotransformation

53 Просмотры

article

5.1 : Drug Biotransformation: Overview

Pharmacokinetics: Drug Biotransformation

248 Просмотры

article

5.2 : Phase I Oxidative Reactions: Overview

Pharmacokinetics: Drug Biotransformation

220 Просмотры

article

5.3 : Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Pharmacokinetics: Drug Biotransformation

127 Просмотры

article

5.5 : Phase I Reactions: Reductive Reactions

Pharmacokinetics: Drug Biotransformation

170 Просмотры

article

5.6 : Phase I Reactions: Hydrolytic Reactions

Pharmacokinetics: Drug Biotransformation

57 Просмотры

article

5.7 : Phase II Conjugation Reactions: Overview

Pharmacokinetics: Drug Biotransformation

134 Просмотры

article

5.8 : Phase II Reactions: Glucuronidation

Pharmacokinetics: Drug Biotransformation

203 Просмотры

article

5.9 : Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Pharmacokinetics: Drug Biotransformation

142 Просмотры

article

5.10 : Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Pharmacokinetics: Drug Biotransformation

122 Просмотры

article

5.11 : Phase II Reactions: Acetylation Reactions

Pharmacokinetics: Drug Biotransformation

150 Просмотры

article

5.12 : Phase II Reactions: Methylation Reactions

Pharmacokinetics: Drug Biotransformation

105 Просмотры

article

5.13 : Phase II Reactions: Miscellaneous Conjugation Reactions

Pharmacokinetics: Drug Biotransformation

34 Просмотры

article

5.14 : Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

Pharmacokinetics: Drug Biotransformation

146 Просмотры

article

5.15 : Factors Affecting Drug Biotransformation: Biological

Pharmacokinetics: Drug Biotransformation

91 Просмотры

JoVE Logo

Исследования

Образование

О JoVE

Авторские права © 2025 MyJoVE Corporation. Все права защищены